CelLBxHealth plc (AIM:CLBX)
London · Delayed Price · Currency is GBP · Price in GBX 1.442
-0.158 (-9.90%)
Jul 7, 2026, 4:28 PM GMT
CelLBxHealth Market Cap
CelLBxHealth has a market cap or net worth of 16.76 million as of July 7, 2026. Its market cap has decreased by -30.49% in one year.
Market Cap
16.76M
Enterprise Value
15.16M
Revenue
2.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.44
Market Cap Chart
Since August 16, 2004, CelLBxHealth's market cap has decreased from 20.37M to 16.76M, a decrease of -17.71%. That is a compound annual growth rate of -0.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 16.76M | 34.09% |
| Dec 31, 2025 | 12.50M | -62.19% |
| Dec 31, 2024 | 33.06M | 8.02% |
| Dec 29, 2023 | 30.60M | -76.73% |
| Dec 30, 2022 | 131.54M | -52.97% |
| Dec 31, 2021 | 279.69M | 172.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 224.22B |
| GSK plc | 80.29B |
| Haleon | 32.12B |
| Smith & Nephew | 9.58B |
| genedrive | 20.87M |
| IXICO | 17.99M |
| Inspiration Healthcare Group | 17.48M |
| Aptamer Group | 16.41M |